Search company, investor...



Other Investors | Alive

About BioPeak

Biopeaks vision is to develop leading edge non-invasive blood analysis devices.  The company's early research focused on lactic acid analysis for the performance athletic market.  As technical results and market information, the company contends that Biopeaks technology was ideal for other larger markets including glucose monitoring. Biopeak is now actively developing a noninvasive glucose analyzer based on its Fusion Spectroscopy technology platform.

Headquarters Location

301 Moodie Drive Suite 304

Ottawa, Ontario, K2H 9C4,



Missing: BioPeak's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioPeak's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BioPeak

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioPeak is included in 1 Expert Collection, including Diabetes.



1,899 items

BioPeak Patents

BioPeak has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics



Electrodes, Electrochemistry, Electroanalytical methods, Neurophysiology, Sensors


Application Date


Grant Date


Related Topics

Electrodes, Electrochemistry, Electroanalytical methods, Neurophysiology, Sensors



BioPeak Frequently Asked Questions (FAQ)

  • Where is BioPeak's headquarters?

    BioPeak's headquarters is located at 301 Moodie Drive, Ottawa.

  • What is BioPeak's latest funding round?

    BioPeak's latest funding round is Other Investors.

  • Who are the investors of BioPeak?

    Investors of BioPeak include BDC Venture Capital.

  • Who are BioPeak's competitors?

    Competitors of BioPeak include Cyberheart, Ornim Medical, ASL Analytical, DIRAmed, OrSense and 11 more.

Compare BioPeak to Competitors


DIRAmed is developing non-invasive meters that measure the levels of key constituents of the human body such as glucose, ketones, cholesterol, and therapeutic drugs. DIRAmed's meters will improve the process by which diabetics and other patients taking therapeutic drugs monitor the levels of components in blood and tissue. DIRAmed currently has investigational prototypes in clinical studies for use in improving tight glycemic control in hospital critical care continuous glucose monitoring applications. DIRAmed is also discussing other designs with selected strategic partners including the development of mobile units for personal use with or without connection to an insulin pump.


OrSense provides non-invasive monitoring of various blood constituencies.


Renovar, Inc. was founded in 1999 by an internationally-recognized UW-Madison transplant surgeon. The company is developing diagnostic tests for kidney disease and transplant monitoring based on Renovar's patented method. The company's approach couples protein biomarkers and the company's urine buffer system, which permits assaying of urine not possible otherwise. The method aims to enable the potential for non-invasive, timelier disease detection with greater sensitivity and specificity.


Truthtek is a spin-out company from Manchester Metropolitan University with a suite of software for the analysis of non-verbal behaviour in video streams of structured interviews. The technology combines latest psychological research in non-verbal communication with leading image recognition and analysis software. Potential applications include lie detection, where the technology is non-invasive and has shown 85% accuracy in initial trials. MTF has provided initial seed capital to the company to enable it to develop its commercial and market-entry strategy.

NeuroSky Logo

NeuroSky is at the forefront of body and mind monitoring and analysis. Its technologies are at the core of innovative, wearable health and wellness consumer products. NeuroSky makes it possible for millions of consumers to capture and quantify critical health and wellness data so that they can effectively manage their mind and body health. NeuroSky delivers uniquely adaptable chips and algorithms that offer ECG multi-function cardio monitoring, and quantitive and interpretive algorithms in a powerful integrated, adaptable and extensible solution.

Ornim Medical Logo
Ornim Medical

Ornim specializes in clinical research, development, and distribution of the highest quality medical devices in the field of tissue and cerebral blood flow and perfusion. The Company's leading product, the c-FLOW, is a bedside patient monitor based on the patented UTLight technology that provides physicians with unique monitoring solutions, revolutionizing individualized and personalized patient care.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.